An ancient herbal remedy that constitutes the active ingredient in a modern diabetes drug may soon play a new role in combating cancer, two studies show. The findings, published in the September
Cancer Prevention Research,
support earlier population studies suggesting that diabetes patients receiving the drug, called metformin, are less prone to develop cancer.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.